Cited 8 times in
Silencing Daxx increases the anti-tumor activity of a TRAIL/shRNA Bcl-xL-expressing oncolytic adenovirus through enhanced viral replication and cellular arrest
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김주항 | - |
dc.contributor.author | 송재진 | - |
dc.date.accessioned | 2016-02-04T11:06:47Z | - |
dc.date.available | 2016-02-04T11:06:47Z | - |
dc.date.issued | 2015 | - |
dc.identifier.issn | 0898-6568 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/139692 | - |
dc.description.abstract | We previously showed that an increase of cellular Bcl-xL mediates acquired resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and knockdown of Bcl-xL expression greatly sensitized TRAIL-induced cytotoxicity. Here, we show that Daxx downregulation increases the anti-tumorigenic activity through enhancement of viral replication and cellular arrest with combination of TRAIL/shBcl-xL-induced apoptosis. This study was conducted to determine the effect of Daxx downregulation on the anti-tumorigenesis induced by oncolytic adenovirus arming TRAIL or TRAIL/shRNA of Bcl-xL genes. Unlike the enhanced cancer cell death induced by exogenous TRAIL or TRAIL plus shRNA of Bcl-xL, oncolytic adenovirus expressing TRAIL or TRAIL plus shRNA of Bcl-xL did not show much enhanced cancer cell death compared to oncolytic adenovirus itself. On the other hand, enhanced cytotoxic cell death and viral replication was observed after infection with oncolytic adenovirus expressing TRAIL plus shRNA of Bcl-xL and shRNA of Daxx at the same construct. Then we realized that enhanced adenoviral replication through Daxx downregulation was caused by increased adenoviral E1A protein expression and Daxx downregulation also stimulated cellular arrest through p21/p53 accumulation. Taken all together, we have shown here that Daxx downregulation should be essentially needed for the increase of anti-tumor activity through enhancement of viral replication and cellular arrest with the combination of TRAIL/shBcl-xL-induced apoptosis and oncolytic adenovirus. | - |
dc.description.statementOfResponsibility | open | - |
dc.format.extent | 1214~1224 | - |
dc.relation.isPartOf | CELLULAR SIGNALLING | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Adaptor Proteins, Signal Transducing/antagonists & inhibitors | - |
dc.subject.MESH | Adaptor Proteins, Signal Transducing/genetics | - |
dc.subject.MESH | Adaptor Proteins, Signal Transducing/metabolism* | - |
dc.subject.MESH | Adenoviridae/physiology* | - |
dc.subject.MESH | Adenovirus E1A Proteins/metabolism | - |
dc.subject.MESH | Animals | - |
dc.subject.MESH | Apoptosis | - |
dc.subject.MESH | Cell Line, Tumor | - |
dc.subject.MESH | Down-Regulation | - |
dc.subject.MESH | G2 Phase Cell Cycle Checkpoints | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | M Phase Cell Cycle Checkpoints | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Mice | - |
dc.subject.MESH | Mice, Inbred BALB C | - |
dc.subject.MESH | Mice, Nude | - |
dc.subject.MESH | Nuclear Proteins/antagonists & inhibitors | - |
dc.subject.MESH | Nuclear Proteins/genetics | - |
dc.subject.MESH | Nuclear Proteins/metabolism* | - |
dc.subject.MESH | RNA Interference* | - |
dc.subject.MESH | RNA, Small Interfering/metabolism | - |
dc.subject.MESH | TNF-Related Apoptosis-Inducing Ligand/genetics | - |
dc.subject.MESH | TNF-Related Apoptosis-Inducing Ligand/metabolism* | - |
dc.subject.MESH | Transplantation, Heterologous | - |
dc.subject.MESH | Virus Replication | - |
dc.subject.MESH | bcl-X Protein/antagonists & inhibitors | - |
dc.subject.MESH | bcl-X Protein/genetics | - |
dc.subject.MESH | bcl-X Protein/metabolism* | - |
dc.title | Silencing Daxx increases the anti-tumor activity of a TRAIL/shRNA Bcl-xL-expressing oncolytic adenovirus through enhanced viral replication and cellular arrest | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학) | - |
dc.contributor.googleauthor | Sujin Kang | - |
dc.contributor.googleauthor | Dongxu Kang | - |
dc.contributor.googleauthor | S.M. Bakhtiar Ul Islam | - |
dc.contributor.googleauthor | Suyeon Je | - |
dc.contributor.googleauthor | Joo-Hang Kim | - |
dc.contributor.googleauthor | Jae J. Song | - |
dc.identifier.doi | 10.1016/j.cellsig.2015.02.028 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A00945 | - |
dc.contributor.localId | A02056 | - |
dc.relation.journalcode | J00502 | - |
dc.identifier.eissn | 1873-3913 | - |
dc.identifier.pmid | 25748050 | - |
dc.identifier.url | http://www.sciencedirect.com/science/article/pii/S0898656815000741 | - |
dc.subject.keyword | Bcl-xL | - |
dc.subject.keyword | Daxx | - |
dc.subject.keyword | Oncolytic adenovirus | - |
dc.subject.keyword | TRAIL | - |
dc.subject.keyword | shRNA | - |
dc.contributor.alternativeName | Kim, Joo Hang | - |
dc.contributor.alternativeName | Song, Jae Jin | - |
dc.contributor.affiliatedAuthor | Kim, Joo Hang | - |
dc.contributor.affiliatedAuthor | Song, Jae Jin | - |
dc.rights.accessRights | not free | - |
dc.citation.volume | 27 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 1214 | - |
dc.citation.endPage | 1224 | - |
dc.identifier.bibliographicCitation | CELLULAR SIGNALLING, Vol.27(6) : 1214-1224, 2015 | - |
dc.identifier.rimsid | 52956 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.